Key facts
- Notable investors include Acelerar España, MTIP.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Verifarma
- ·The full record, as it builds
Funding rounds
No funding rounds for Verifarma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Verifarma
Developer of a pharmaceutical traceability and quality management platform designed to ensure patient safety and regulatory compliance. The company's platform offers integrated systems for quality assurance, control, pharmacovigilance, and traceability, enabling pharmaceutical manufacturers and distributors to maintain product integrity and meet global compliance standards.
- Sector
- Healthcare
- HQ
- Las Palmas de Gran Canaria, Spain
- Founded
- 2007
- Employees
- 110
- Website
- verifarma.com/
- Ownership
- Privately Held (backing)
Verifarma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Verifarma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Verifarma in its N-PORT filings yet. We sweep new filings monthly.